Administration of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy; a new strategy in the management?

Some of the several effects of sodium-glucose cotransporter-2 inhibitors (SGLT-2i), including their metabolic, anti-inflammatory and hemodynamic properties, along with other kidney protective values, have directed clinicians to give these drugs in IgA-nephropathy (IgAN). According to recent studies...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anastasia Dieti, Yeganeh Ragati Haghi, Majid Forootan
Format:	Artigo
Idioma:	Inglês
Publicat:	Society of Diabetic Nephropathy Prevention 2026-01-01
Col·lecció:	Journal of Nephropathology
Matèries:	sodium-glucose cotransporter-2 inhibitors chronic kidney disease iga-nephropathy diabetic kidney disease acute kidney disease albuminuria
Accés en línia:	https://nephropathol.com/PDF/jnp-15-e21429.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!